Restoration of Cellular Immunity Against Tuberculosis in Patients Coinfected With HIV-1 and Tuberculosis With Effective Antiretroviral Therapy: Assessment by Determination of CD69 Expression on T Cells After Tuberculin Stimulation

This publication has 32 references indexed in Scilit:

• Occurrence of Pneumocystis carinii pneumonia in HIV-1-infected patients responding to HAART: is prophylaxis discontinuation a safe tool?
  AIDS, 1999
• Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy
  New England Journal of Medicine, 1999
• Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy
  AIDS, 1998
• Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities
  AIDS, 1998
• Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposiʼs sarcoma
  AIDS, 1998
• Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
  The Lancet, 1998
• The Immune Response in Human Tuberculosis—Implications for Tuberculosis Control
  The Journal of Infectious Diseases, 1997
• Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir
  The Journal of Infectious Diseases, 1996
• Th1 and Th2 cells in the cure and pathogenesis of infectious diseases
  Current Opinion in Infectious Diseases, 1995
• Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors.
  The Journal of Experimental Medicine, 1993